Iterum Therapeutics plc
ITRMDelisted Jun 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659323
Iterum Therapeutics plc was delisted on Jun 23, 2026; its insiders filed their last Form 4 on Nov 20, 2025; 18 institutions reported holding it in 13F filings for Q1 2026, worth $41.3K in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Iterum Therapeutics plc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 39 | 25 | −14 |
| SharesConverted for a 1-for-15 split | 392.4K | 317.9K | −74.5K (−19.0%) |
| Value | $1.18M | $575.4K | −$600.4K (−51.1%) |
New holders (2)
Institutions that held Iterum Therapeutics plc at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Dimensional Fund Advisors LP | 62,301 | $101.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,322 | $2.00K | 0.00% |
Sold out (16)
Institutions that held Iterum Therapeutics plc at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Canaan Partners X LLC | 1,733,170 | $346.0K |
| Goldman Sachs Group Inc | 304,684 | $61.0K |
| Gsa Capital Partners LLP | 304,684 | $61.0K |
| Verition Fund Management LLC | 112,500 | $23.0K |
| Virtu Financial LLC | 110,470 | $22.0K |
| Geode Capital Management, LLC | 92,095 | $18.0K |
| Millennium Management LLC | 88,101 | $18.0K |
| Brown Advisory Inc | 60,000 | $12.0K |
| Squarepoint Ops LLC | 44,442 | $9.00K |
| Citigroup Inc | 40,000 | $8.00K |
| Principle Wealth Partners LLC | 30,000 | $6.00K |
| Geneos Wealth Management Inc. | 20,000 | $4.00K |
| Savant Capital, LLC | 13,888 | $3.00K |
| Resources Investment Advisors, LLC. | 16,556 | $3.00K |
| Blue Bell Private Wealth Management, LLC | 1,000 | $0 |
| Captrust Financial Advisors | 500 | $0 |